LSX Nordic Congress White

 

INTERNATIONAL STRATEGY, INVESTMENT, PARTNERING AND DEAL MAKING FOR NORDIC LIFE SCIENCE EXECUTIVE LEADERS


5th Annual Congress



6-7 September, 2022
Bella Sky, Center Blvd. 5, 2300
Copenhagen, Denmark

DOWNLOAD BROCHURE

What is the LSX Nordic Congress?


The LSX Nordic Congress is the leading senior executive strategy, investment and partnering conference for the Nordic region.

It connects life science and healthcare industry leaders with international investment and strategic partners to further the growth, development and internationalisation of Nordic life science and healthcare innovation.

The mission is to facilitate ever greater international investment into the region, as well as foster strategic partnerships and collaboration with international healthcare stakeholders

After four years in Stockholm, and as we return in-person in 2022, we are delighted to be hosting the 5th LSX Nordic Congress in Copenhagen, Denmark! As the hub of Medicon Valley, the crucible of Scandinavian life sciences, we can’t wait to welcome you all to Copenhagen in September!

LSX Nordic Congress

DOWNLOAD BROCHURE

The premier virtual experience for Nordic leaders in life sciences investment, technology, business and strategy

2021 Speakers included


Stephan Christgau, Managing Partner, Eir Ventures

Stephan Christgau

Managing Partner
Eir Ventures
Tahera Kan, VP Head of New Ventures & Transactions, Johnson & Johnson

Tahera Kan

VP Head of New Ventures & Transactions
Johnson & Johnson
Anna-Karin Edstedt Bonamy, CEO, Doctrin

Anna-Karin Edstedt Bonamy

CEO
Doctrin
Ingrid Teigland Akay, Managing Partner, Hadean Ventures

Ingrid Teigland Akay

Managing Partner
Hadean Ventures
Bobby Soni, CBO, BII

Bobby Soni

CBO
BII
Keld Flintholm Jørgensen, EVP & CBO, Lundbeck

Keld Flintholm Jørgensen

EVP & CBO
Lundbeck
Renee Aguiar-Lucander, CEO, Calliditas Therapeutics

Renee Aguiar-Lucander

CEO
Calliditas Therapeutics
Søren Lemonius, Managing General Partner, Sunstone Life Science Ventures

Søren Lemonius

Managing General Partner
Sunstone Life Science Ventures
James Stamatis, Vice President, Head of Business Development and Acquisitions, AbbVie

James Stamatis

Vice President, Head of Business Development and Acquisitions
AbbVie
Petrina Knowles Gjelstrup, SVP People & Organisation, Novo Holdings

Petrina Knowles Gjelstrup

SVP People & Organisation
Novo Holdings & The Novo Nordisk Foundation
Anders Martin-Löf, CFO, Oncopeptides

Anders Martin-Löf

CFO
Oncopeptides
Nathalie ter Wengel, European Lead Worldwide Business Development, Pfizer

Nathalie ter Wengel

European Lead Worldwide Business Development
Pfizer

ALL SPEAKERS

400+
participants

150+
international investors & pharma

1500+
c-suite company executives

2 days
1:1  partnering

30+
company showcases

Platinum sponsors


Back Bay Life Science Advisors

Nasdaq

Gold sponsors


Coulter Partners

Covington 300x150

Mintz

MSC Nordics

Potter Clarkson

Willis Towers Watson

Bronze sponsor


DFIN

DOWNLOAD BROCHURE
Female Founders

Networking, Dialogue And Mentorship For Women In Health And Life Sciences
Members save 25% off all LSX events.

FIND OUT MORE

Subscribe to hear speaker announcements, ticket offers and more